Evidence-based guideline summary: Evaluation, diagnosis, and management of congenital muscular dystrophy

Neurology

Volumn 84, Issue 13, 2015, Pages 1369-1378

  Kang, Peter B ^a,b   Morrison, Leslie ^c   Iannaccone, Susan T ^d   Graham, Robert J ^b   Bönnemann, Carsten G ^e   Rutkowski, Anne ^f,g   Hornyak, Joseph ^h   Wang, Ching H ^i,j   North, Kathryn ^k   Oskoui, Maryam ^l   Getchius, Thomas S D ^m   Cox, Julie A ^m   Hagen, Erin E ^m   Gronseth, Gary ⁿ   Griggs, Robert C ^o  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^f Cure Congenital Muscular Dystrophy (Cure CMD)   (United States)

^g KAISER PERMANENTE   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j Driscoll Childrens Hospital   (United States)

^k UNIVERSITY OF MELBOURNE   (Australia)

^l MCGILL UNIVERSITY   (Canada)

^m AMERICAN ACADEMY OF NEUROLOGY   (United States)

ⁿ UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; DYSPHAGIA; ETHNICITY; EVIDENCE BASED PRACTICE; GENETIC SCREENING; HUMAN; LUNG COMPLICATION; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL DEFICIENCY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCOLIOSIS; SEIZURE; DISEASE MANAGEMENT; EVIDENCE BASED MEDICINE; MUSCULAR DYSTROPHIES; ORGANIZATION; PRESCHOOL CHILD;

ACADEMIES AND INSTITUTES; CHILD, PRESCHOOL; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; HUMANS; MUSCULAR DYSTROPHIES;

EID: 84929517990     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001416     Document Type: Article

References (40)

1. American Academy of Neurology. Clinical Practice Guidelines Process Manual, 2004 ed. St. Paul,MN: The American Academy of Neurology; 2004. Available at: https://www. aan.com/Guidelines/Home/Development. Accessed February 12, 2012. Published 2004.
2. American Academy of Neurology. Clinical Practice Guidelines Process Manual, 2011 ed. St. Paul,MN: The American Academy of Neurology; 2011. Available at: https://www. aan.com/Guidelines/Home/Development. Accessed February 12, 2012. Published August 2011.
3. Floriach-Robert M, Cabello A, Simon De Las Heras R, Mateos Beato F. Neonatal hypotonia of muscular origin: analysis of 50 cases [in Spanish]. Neurologia 2001;16:245-253.
4. Mostacciuolo ML, Miorin M, Martinello F, Angelini C, Perini P, Trevisan CP. Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy. Hum Genet 1996;97:277-279.
5. Darin N, Tulinius M. Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden. Neuromuscul Disord 2000;10:1-9.
6. Bonnemann CG, Wang CH, Quijano-Roy S, et al. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord 2014;24:289-311.
7. Bonnemann CG. The collagen VI-related myopathies: muscle meets its matrix. Nat Rev Neurol 2011;7:379-390.
8. Bonnemann CG. The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy. Handb Clin Neurol 2011;101:81-96.
9. Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type: clinical, genetic and pathological considerations. Brain Dev 1981;3:1-29.
10. Manzini MC, Tambunan DE, Hill RS, et al. Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome. Am J Hum Genet 2012;91:541-547.
11. Vuillaumier-Barrot S, Bouchet-Saraphin C, Chelbi M, et al. Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly. Am J Hum Genet 2012;91:1135-1143.
12. Stevens E, Carss KJ, Cirak S, et al. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of a-dystroglycan. Am J Hum Genet 2013;92:354-365.
13. Jae LT, Raaben M, Riemersma M, et al. Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry. Science 2013;340:479-483.
14. Buysse K, Riemersma M, Powell G, et al. Missense mutations in b-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome. Hum Mol Genet 2013; 22:1746-1754.
15. Carss KJ, Stevens E, Foley AR, et al. Mutations in GDPmannose pyrophosphorylase B cause congenital and limbgirdle muscular dystrophies associated with hypoglycosylation of a-dystroglycan. Am J Hum Genet 2013;93:29-41.
16. Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, et al. A dystroglycan mutation associated with limb-girdle muscular dystrophy. N Engl J Med 2011;364:939-946.
17. Kato R, Kawamura J, Sugawara H, Niikawa N, Matsumoto N. A rapid diagnostic method for a retrotransposal insertional mutation into the FCMD gene in Japanese patients with Fukuyama congenital muscular dystrophy. Am J Med Genet A 2004;127A:54-57.
18. Chang W, Winder TL, LeDuc CA, et al. Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families. Prenat Diagn 2009;29:560-569.
19. Balci B, Uyanik G, Dincer P, et al. An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene. Neuromuscul Disord 2005;15:271-275.
20. Helbling-Leclerc A, Zhang X, Topaloglu H, et al. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995;11:216-218.
21. Chae JH, Lee JS, Hwang H, et al.Merosin-deficient congenital muscular dystrophy in Korea. Brain Dev 2009;31:341-346.
22. Lim BC, Ki CS, Kim JW, et al. Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea. Neuromuscul Disord 2010; 20:524-530.
23. Camacho Vanegas O, Bertini E, Zhang RZ, et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci USA 2001; 98:7516-7521.
24. Aparicio Meix JM, Pascual-Castroviejo I. Ullrich syndrome: a hypotonic disorder of early infancy, difficult to define as an entity. An Esp Pediatr 1980;13:979-984.
25. Herrmann R, Straub V, Meyer K, Kahn T, Wagner M, Voit T. Congenital muscular dystrophy with laminin alpha 2 chain deficiency: identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry. Eur J Pediatr 1996;155:968-976.
26. Godfrey C, Clement E, Mein R, et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 2007;130: 2725-2735.
27. Diesen C, Saarinen A, Pihko H, et al. POMGnT1 mutation and phenotypic spectrum in muscle-eye-brain disease. J Med Genet 2004;41:e115.
28. Auranen M, Rapola J, Pihko H, et al. Muscle membraneskeleton protein changes and histopathological characterization of muscle-eye-brain disease. Neuromuscul Disord 2000;10:16-23.
29. Cotarelo RP, Fano O, Raducu M, et al. A double homozygous mutation in the POMT1 gene involving exon skipping gives rise to Walker-Warburg syndrome in two Spanish Gypsy families. Clin Genet 2009;76:108-112.
30. Menezes MP, Waddell LB, Evesson FJ, et al. Importance and challenge of making an early diagnosis in LMNA-related muscular dystrophy. Neurology 2012;78:1258-1263.
31. Lamer S, Carlier RY, Pinard JM, et al. Congenital muscular dystrophy: use of brain MR imaging findings to predict merosin deficiency. Radiology 1998;206:811-816.
32. Aida N, Yagishita A, Takada K, Katsumata Y. Cerebellar MR in Fukuyama congenital muscular dystrophy: polymicrogyria with cystic lesions. AJNR Am J Neuroradiol 1994;15:1755-1759.
33. Bindu PS, Gayathri N, Bharath RD, Mahadevan A, Sinha S, Taly AB. Pattern recognition on brain magnetic resonance imaging in alpha dystroglycanopathies. Neurol India 2010;58:460-465.
34. Brockmann K, Becker P, Schreiber G, Neubert K, Brunner E, Bonnemann C. Sensitivity and specificity of qualitative muscle ultrasound in assessment of suspected neuromuscular disease in childhood. Neuromuscul Disord 2007;17:517-523.
35. Aydinli N, Baslo B, Caliskan M, Ertas M, Ozmen M. Muscle ultrasonography and electromyography correlation for evaluation of floppy infants. Brain Dev 2003;25:22-24.
36. Mercuri E, Clements E, Offiah A, et al. Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine. Ann Neurol 2010;67: 201-208.
37. Deconinck N, Dion E, Ben Yaou R, et al. Differentiating Emery-Dreifuss muscular dystrophy and collagen VI-related myopathies using a specific CT scanner pattern. Neuromuscul Disord 2010;20:517-523.
38. Hayashi YK, Koga R, Tsukahara T, et al. Deficiency of laminin alpha 2-chain mRNA in muscle in a patient with merosin-negative congenital muscular dystrophy. Muscle Nerve 1995;18:1027-1030.
39. Ferreira LG, Marie SK, Liu EC, et al. Dystrophin-glycoproteins associated in congenital muscular dystrophy: immunohistochemical analysis of 59 Brazilian cases. Arq Neuropsiquiatr 2005;63:791-800.
40. Geranmayeh F, Clement E, Feng LH, et al. Genotypephenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. Neuromuscul Disord 2010;20:241-250.